FDA Clearance for Spectra™ VRE Chromogenic Media
Thermo Fisher Scientific Inc. has received FDA clearance for Spectra™ VRE, a test designed to screen for vancomycin-resistant Enterococcus (VRE). Spectra VRE is the first chromogenic media for the 24-hour detection of VRE colonization with rectal swabs and stool specimens.
Spectra VRE is a ready-to-use test medium that can differentiate between vancomycin-resistant E. faecalis and E.faecium within 24 hours with no confirmatory testing required.
To learn more about Spectra VRE or other Remel solutions for healthcare associated infections, visit www.remel.com/hai.
Source: Remel Inc. View latest company information
Posted: September 6, 2010
[will open your email client]